Patent EP0380666A1 successfully refreshed from Google Patents.
← Back to Patent Explorer
EP0154447B1 Expired / Lapsed EP ⏱️ 0.0 years remaining

Compositions and method for improving wound healing

Assignee: University of California, San Diego
•
Filing: 1985-02-20
•
Granted: 1990-12-05
•
Expires: 2005-02-20
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract The healing of wounds is promoted by contacting the wound surfaces with a suspension of collagen and a glycosaminoglycan that is chemotactic for fibroblasts and/or endothelial cells. Typical glycosaminoglycans that exhibit the desired chemotaxis are heparin, heparan sulfate, and alginate. Two or more glycosaminoglycans can be present in the suspensions. Collagen is present in the suspension in the order of 7-10 mg/ml; while the glycosaminoglycan is present in much lower concentrations, e.g, 250-350 µg/ml. Application of the collagen/glycosaminoglycan suspension to open wounds greatly increases the rate of healing.

Inventors

  • 👤 Dov Michaeli

Bibliographic Details

Application Number —
Jurisdiction EP
Data Source google_patents
Last Synchronized 2026-10-23 12:53
CPC Classifications
A; A61; A61K; A61K38/00; A61K38/16; A61K38/17; A61K38/39; A61P; A61P17/00

Claims Analysis

Total Claims: 13
Claim 1
Independent Claim 41 words
A composition for use in promoting wound healing which is an aqueous suspension including a major amount of collagen and a minor amount of one or more glycosaminoglycans ("GAGs") selected for its or their chemotactic effect on fibroblasts or endothelial cells.
Claim 2
Dependent Claim 41 words
A composition for use in promoting wound healing which is an aqueous suspension including a major amount of collagen and a minor amount of one or more glycosaminoglycans ("GAGs") selected for its or their chemotactic effect on fibroblasts or endothelial cells.
Claim 3
Dependent Claim 14 words
A composition according to Claim 1 wherein the suspension is in saline aqueous solution.
Claim 4
Dependent Claim 29 words
A composition according to Claim 2 wherein the solution is isotonic saline solution, and the collagen is present at a concentration of from 7 to 10 milligrams per millilitre.
Claim 5
Dependent Claim 30 words
A composition according to Claim 2 or Claim 3 wherein the GAG(s) is present or are in total present at a concentration of from 100 to 1000 micrograms per millilitre.
Claim 6
Dependent Claim 30 words
A composition according to Claim 2, Claim 3 or Claim 4 wherein the concentration of collagen is about 8.75 pg/ml and the concentration of the GAG(s) is about 280 Ilg/ml.
Claim 7
Dependent Claim 27 words
A composition according to any one of the preceding Claims wherein the GAG(s) is or are heparin (optionally in the form of its sulfate) and/or an alginate.
Claim 8
Dependent Claim 21 words
A composition according to any one of the preceding Claims wherein the ratio of collagen to GAG(s) is 25:1 to 35:1.
Claim 9
Dependent Claim 13 words
A dressing comprising a composition according to any one of the preceding Claims.
Claim 10
Dependent Claim 21 words
The use of an admixture of collagen and GAG(s) in the manufacture of a composition or dressing for promoting wound healing.
Claim 11
Dependent Claim 21 words
The use of an admixture of collagen and GAG(s) in the manufacture of a composition or dressing for promoting wound healing.
Claim 12
Independent Claim 44 words
A method of preparing a composition for use in promoting wound healing comprising forming an aqueous suspension including a major amount of collagen and a minor amount of one or more GAG's selected for its or their chemotactic effect on fibroblasts or endothelial cells.
Claim 13
Independent Claim 44 words
A method of preparing a composition for use in promoting wound healing comprising forming an aqueous suspension including a major amount of collagen and a minor amount of one or more GAG's selected for its or their chemotactic effect on fibroblasts or endothelial cells.

References Cited (Backward Citations)

No citation records indexed.

USPTO Annuity & Maintenance Windows

Maintenance schedule is calculated for granted US utility patents.

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag